Citizens Financial Group »

Lineage Cell Therapeutics In shares owned by Citizens Financial Group

Quarter-by-quarter ownership of Lineage Cell Therapeutics In (LCTX) shares owned by Citizens Financial Group from 13F filings

Historical chart of Citizens Financial Group investment in Lineage Cell Therapeutics In

Tip: Access up to 7 years of quarterly data

All positions including Lineage Cell Therapeutics In held by Citizens Financial Group consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Lineage Cell Therapeutics In by Citizens Financial Group

Quarter filed Position value Share count Share price at filing
2025-09-30 $25k 15k 1.69

More positions owned by Citizens Financial Group

Vanguard Index Fds S&p 500 Etf Shs (VOO)
Apple (AAPL)
NVIDIA Corporation (NVDA)
Microsoft Corporation (MSFT)
Ishares Tr Core S&p500 Etf (IVV)
Ishares Tr Core S&p Mcp Etf (IJH)
Ishares Tr Core Msci Eafe (IEFA)
Alphabet Cap Stk Cl A (GOOGL)
Spdr S&p 500 Etf Tr Tr Unit (SPY)
Amazon (AMZN)
Vanguard Index Fds Value Etf (VTV)
JPMorgan Chase & Co. (JPM)
Procter & Gamble Company (PG)
Facebook Cl A (META)
Ishares Core Msci Emkt (IEMG)

View all positions for Citizens Financial Group

Top funds holding Lineage Cell Therapeutics In

Broadwood Capital
Vanguard Group
Raffles Associates
Brian McDonald
Millennium Management
Geode Capital Management
BlackRock
Renaissance Technologies
Dauntless Investment Group
State Street Corporation
Morgan Stanley
GSA Capital Partners
Red Crane Wealth Management
Northern Trust
Eudaimonia Asset Management

View all funds holding Lineage Cell Therapeutics In